Phase III study of T-3262G15% in the pediatric patients with mycoplasma pneumonia

Trial Profile

Phase III study of T-3262G15% in the pediatric patients with mycoplasma pneumonia

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Aug 2016

At a glance

  • Drugs Tosufloxacin (Primary) ; Clarithromycin
  • Indications Mycoplasmal pneumonia
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Toyama Chemical
  • Most Recent Events

    • 25 Aug 2016 New trial record
    • 03 Feb 2016 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top